In vitro/in vivo evaluation of agar nanospheres for pulmonary delivery of bupropion HCl

References

• Ammar HO, Salama HA, Ghorab M, Mahmoud AA. (2009). Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride. Aaps Pharmscitech 10:808–19
   PubMed Web of Science ®Google Scholar
• Brunton L, Lazo S, Parker L. (2006). Goodman & Gilman’s the pharmacological basis of therapeutics. 11th ed. New York: McGraw-Hill Professional Publishing
   Google Scholar
• Brustolim D, Ribeiro-dos-Santos R, Kast RE, et al. (2006). A new chapter opens in anti-inflammatory treatments: the antidepressant bupropion lowers production of tumor necrosis factor-alpha and interferon-gamma in mice. Int Immunopharmacol 6:903–7
   PubMed Web of Science ®Google Scholar
• Cantwell DP. (1997). ADHD through the life span: the role of bupropion in treatment. J Clin Psychiatry 59:92–4
   Web of Science ®Google Scholar
• Cazacu R, Grama L. (2014). Steel truss optimization using genetic algorithms and FEA. Procedia Technol 12:339–46
   Google Scholar
• Deli MA. (2009). Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Biochim Biophys Acta Biomembr 1788:892–910
   PubMed Web of Science ®Google Scholar
• Fathi M, Mohebbi M, Razavi S. (2011a). Application of image analysis and artificial neural network to predict mass transfer kinetics and color changes of osmotically dehydrated kiwifruit. Food Bioprocess Technol 4:1357–66
   Web of Science ®Google Scholar
• Fathi M, Mohebbi M, Razavi SMA. (2011b). Application of fractal theory for prediction of shrinkage of dried kiwifruit using artificial neural network and genetic algorithm. Drying Technol 29:918–25
   Web of Science ®Google Scholar
• Ghaderpour S, Zare S, Ghaderi Pakdel F. (2010). Effects of acute intra-hippocompal injection of bupropion on active avoidance learning in rats. Physiol Pharmacol 14:293–301
   Google Scholar
• Gondaliya DP, Pundarikakshudu K. (2003a). Enhanced transdermal permeation of bupropion hydrochloride by chemical modification. Ind J Pharm Sci 65:671–4
   Google Scholar
• Gondaliya DP, Pundarikakshudu K. (2003b). Studies in formulation and pharmacotechnical evaluation of controlled release transdermal delivery system of bupropion. AAPS PharmSciTech 4:18–26
   Google Scholar
• Hays JT, Hurt RD, Decker PA, et al. (2009). A randomized, controlled trial of bupropion sustained-release for preventing tobacco relapse in recovering alcoholics. Nicotine Tob Res 11:859–67
   PubMed Web of Science ®Google Scholar
• Heckerling PS, Gerber BS, Tape TG, Wigton RS. (2004). Use of genetic algorithms for neural networks to predict community-acquired pneumonia. Artif Intel Med 30:71–84
   PubMed Web of Science ®Google Scholar
• Izadifar M, Jahromi MZ. (2007). Application of genetic algorithm for optimization of vegetable oil hydrogenation process. J Food Eng 78:1–8
   Web of Science ®Google Scholar
• Jorenby DE, Hays JT, Rigotti NA, et al. Varenicline Phase 3 Study Group (2006). Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 296:56–63
   PubMed Web of Science ®Google Scholar
• Khan KA, Rhodes CT. (1972). Effect of compaction pressure on the dissolution efficiency of some direct compression systems. Pharm Acta Helv 47:594–607
   PubMedGoogle Scholar
• Kim D, Steinhart B. (2010). Seizures induced by recreational abuse of bupropion tablets via nasal insufflation. Canad J Emerg Med Care 12:158–61
   Web of Science ®Google Scholar
• Kiptoo PK, Paudel KS, Hammell DC, et al. (2009). Transdermal delivery of bupropion and its active metabolite, hydroxybupropion: a prodrug strategy as an alternative approach. J Pharm Sci 98:583–94
   PubMed Web of Science ®Google Scholar
• Labbate LA, Grimes JB, Hines A, Pollack MH. (1997). Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction. Ann Clin Psychiatry 9:241–5
   PubMedGoogle Scholar
• Laizure SC, DeVane CL, Stewart JT, et al. (1985). Pharmacokinetics of bupropion and its major basic metabolites in normal subjects after a single dose. Clin Pharmacol Ther 38:586–9
   PubMed Web of Science ®Google Scholar
• Langguth B, Hajak G, Landgrebe M, Unglaub W. (2009). Abuse potential of bupropion nasal insufflation: a case report. J Clin Psychopharmacol 29:618–19
   PubMed Web of Science ®Google Scholar
• Liversidge GG, Cundy KC. (1995). Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. Int J Pharm 125:91–7
   Web of Science ®Google Scholar
• Loboz KK, Gross AS, Ray J, McLachlan AJ. (2005). HPLC assay for bupropion and its major metabolites in human plasma. J Chromgr B Anal Technol Biomed Life Sci 823:115–21
   PubMed Web of Science ®Google Scholar
• Loftsson T, Brewster ME. (2011). Pharmaceutical applications of cyclodextrins: effects on drug permeation through biological membranes. J Pharm Pharmacol 63:1119–35
   PubMed Web of Science ®Google Scholar
• Lufeng H, Wang Z, Xu R, et al. (2011). Determination of bupropion and its main metabolite in rat plasma by LC–MS and its application to pharmacokinetics. Die Pharm Int J Pharm Sci 66:924–8
   Google Scholar
• McCall J. 2005. Genetic algorithms for modelling and optimisation. J Comput Appl Math 184:205–22
   Web of Science ®Google Scholar
• Modell JG, Rosenthal NE, Harriett AE, et al. (2005). Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL. Biol Psychiatry 58:658–67
   PubMed Web of Science ®Google Scholar
• Mokhtari Hashtjin M, Zare S, Ghaderi Pakdel F, Heysieattalab S. (2010). The effect of intra-VTA injection of Bupropion on submissive defensive aggressive behavior induced by electrical foot shock of rat. Pharm Sci 16:125–30
   Google Scholar
• Nicoli S, Cella S, Aversa V, Santi P. (2008). Transdermal film containing nicotine and bupropion for combined smoking cessation therapy. PharmTech Eur 20:22–8
   Google Scholar
• Patil JS, Sarasija S. (2012). Pulmonary drug delivery strategies: a concise, systematic review. Lung India Office Organ Indian Chest Soc 29:44–9
   PubMedGoogle Scholar
• Patton JS. (1996). Mechanisms of macromolecule absorption by the lungs. Adv Drug Deliv Rev 19:3–36
   Web of Science ®Google Scholar
• Plodkowski RA, Nguyen Q, Sundaram U, et al. (2009). Bupropion and naltrexone: a review of their use individually and in combination for the treatment of obesity. Expert Opin Pharmacother 10:1069–81
   PubMed Web of Science ®Google Scholar
• Shaikh S, Nazim S, Shaikh A, et al. (2011). Recent trends in applications of pulmonary drug delivery: a review. Int J Pharm Res Dev 2:171–80
   Google Scholar
• Silverstone PH, Williams R, McMahon L, et al. (2008). Convulsive liability of bupropion hydrochloride metabolites in Swiss albino mice. Ann Gen Psychiatry 7:19–26
   PubMedGoogle Scholar
• Stahl SM, Pradko JF, Haight BR, et al. (2004). A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 6:159–66
   PubMedGoogle Scholar
• Suckow RF, Smith TM, Perumal AS, Cooper TB. (1986). Pharmacokinetics of bupropion and metabolites in plasma and brain of rats, mice, and guinea pigs. Drug Metab Dispos 14:692–7
   PubMed Web of Science ®Google Scholar
• Sun Y, Peng Y, Chen Y, Shukla AJ. (2003). Application of artificial neural networks in the design of controlled release drug delivery systems. Adv Drug Deliv Rev 55:1201–15
   PubMed Web of Science ®Google Scholar
• Sweet RA, Pollock BG, Kirshner M, et al. (1995). Pharmacokinetics of single- and multiple-dose bupropion in elderly patients with depression. J Clin Pharmacol 35:876–84
   PubMed Web of Science ®Google Scholar
• Tewes F, Gobbo OL, Amaro MI, et al. (2011). Evaluation of HPβCD–PEG microparticles for salmon calcitonin administration via pulmonary delivery. Mol Pharm 8:1887–98
   PubMed Web of Science ®Google Scholar
• Xin Y. (1999). Evolving artificial neural networks. Proc IEEE 87:1423–47
   Web of Science ®Google Scholar
• Zhang Y, Huo M, Zhou J, Xie S. (2010). PKSolver: an add-in program for pharmacokinetic and pharmacodynamic data analysis in Microsoft Excel. Comput Methods Programs Biomed 99:306–14
   PubMed Web of Science ®Google Scholar
• Zung WW, Brodie HK, Fabre L, et al. (1983). Comparative efficacy and safety of bupropion and placebo in the treatment of depression. Psychopharmacology 79:343–7
   PubMed Web of Science ®Google Scholar